Indolizidine derivatives as potential substance P antagonists

[1]  H. G. Davies,et al.  Morphan based substance P antagonists , 1996 .

[2]  M. Desai.  Overview: Central & Peripheral Nervous System: Recent advances in the discovery and characterization of substance P antagonists , 1994 .

[3]  R. Hargreaves,et al.  The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. , 1993, European journal of pharmacology.

[4]  C. Bountra,et al.  Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets. , 1993, European journal of pharmacology.

[5]  P. Thadeio,et al.  Synthesis of (±)-CP-99994: A highly potent substance P antagonist , 1993 .

[6]  J. Lowe,et al.  Chapter 11. The Role of Tachykinins in Pulmonary Disease , 1993 .

[7]  P. Thadeio,et al.  Discovery of a potent substance P antagonist: recognition of the key molecular determinant. , 1992, Journal of medicinal chemistry.

[8]  M. Moskowitz.  Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. , 1992, Trends in pharmacological sciences.

[9]  J. Lowe,et al.  A potent nonpeptide antagonist of the substance P (NK1) receptor. , 1991, Science.

[10]  S. Martin,et al.  Application of reductive, single electron transfer processes to the generation and cyclization of ω-unsaturated α-amino radicals , 1988 .

[11]  M. Otsuka,et al.  Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord‐tail preparation of the newborn rat. , 1988, The Journal of physiology.

[12]  Robert F. Francis,et al.  Peripheral synthesis of medium-ring nitrogen heterocycles by displacement reactions , 1972 .